Get the Daily Brief
Latest Biotech News
FGF13 Emerges as Protective Agent Against Age-Related Hearing Loss
Researchers have identified fibroblast growth factor 13 (FGF13) as a critical molecule in preserving neuronal integrity within the inner ear, potentially delaying or halting hearing decline linked...
Novel Epigenetic Biomarkers Enable Noninvasive Nasopharyngeal Cancer Detection
A pioneering diagnostic approach utilizing DNA methylation markers derived from bilateral nasal swabs offers a noninvasive, automated method to detect nasopharyngeal carcinoma (NPC) at early...
Molecular Markers Illuminate Radiosensitivity in Adult Glioma Therapy
New research identifying molecular biomarkers predictive of radiosensitivity in adult gliomas aims to refine radiotherapy strategies for these aggressive brain tumors. Given glioma’s notorious...
Microsoft’s Rural Hospital Initiative Boosts Cybersecurity and AI Innovation
Microsoft is expanding its commitment to rural healthcare by providing discounted cybersecurity tools, free digital training, and establishing an AI innovation lab accessible to over 700 rural...
FDA Faces Morale Crisis Amid Staff Exodus and Political Influence
The Food and Drug Administration (FDA) is struggling with a significant loss of experienced staff and declining morale, factors that threaten to undermine its regulatory effectiveness. Since April...
US-China Relations Hit Biotech as FDA Tightens Oversight on Chinese Drug Trials
Rising political tensions between the U.S. and China have prompted the FDA to implement stricter regulatory measures affecting Chinese-developed drug investments and clinical trials. The agency...
Roche-Backed Chugai Enters Longevity Drug Space with Pfizer Partnership
Chugai Pharmaceutical, part of the Roche group headquartered in Tokyo, has ventured into the aging disease drug development arena through a strategic collaboration with Pfizer-allied Gero. This...
AI Breakthrough in Fertility: Columbia System Finds Sperm Missed by Experts
Researchers at Columbia University have developed an AI system named STAR, adapted from astrophysics algorithms, capable of detecting viable sperm cells overlooked by human embryologists. The...
Novartis Cosentyx Fails Phase 3 Trial for Rare Blood Vessel Disease
Novartis's antibody drug Cosentyx did not achieve its primary endpoint in a Phase 3 clinical trial for treating giant cell arteritis, a rare autoimmune disorder affecting blood vessels. The...
Microsoft Drives Digital Innovation to Bolster Rural Hospital Security
Microsoft is addressing growing cybersecurity and digital infrastructure challenges in rural hospitals through initiatives providing discounted technology, free training, and an AI innovation lab....
European Commission Fines Alchem Over Decade-Long API Price Fixing
The European Commission has penalized pharmaceutical firm Alchem, concluding its involvement in a cartel manipulating active pharmaceutical ingredient (API) prices for over ten years. This closure...
Emerging Research Links FGF13 to Prevention of Age-Related Hearing Loss
A new study identifies fibroblast growth factor 13 (FGF13) as a critical protector of neurons in the inner ear, offering potential therapeutic angles for combating age-associated hearing decline....
Novel Noninvasive DNA Methylation Test Advances Nasopharyngeal Cancer Detection
Researchers have developed a noninvasive diagnostic technique using DNA methylation biomarkers from bilateral nasal swabs to detect nasopharyngeal carcinoma early. Published in BMC Cancer, this...
Glucose Metabolism Governs CD4+ T Cell Differentiation and Immunity
Recent research reveals that glucose metabolism critically influences the fate of naive CD4+ T cells upon activation, impacting adaptive immune responses. These metabolic shifts determine T cell...
AI Revolutionizes Fertility Treatment with Novel Sperm Detection
Columbia University researchers have pioneered an AI system called STAR (Sperm Tracking and Recovery) that detects sperm cells in samples previously deemed sterile by human embryologists. The AI,...
Novartis’ Cosentyx Fails to Advance in Rare Vascular Disease Trial
Novartis reported that its antibody drug Cosentyx did not meet the primary endpoint in a Phase 3 trial for giant cell arteritis, failing to beat placebo. The drug was in development as an...
European Commission Fines Alchem for Decade-Long Drug Ingredient Cartel
The European Commission imposed fines on pharmaceutical ingredient manufacturer Alchem following an investigation that uncovered cartel activities spanning over ten years. The probe centered on...
Microsoft Drives Digital Innovation to Strengthen Rural Hospital Cybersecurity
Microsoft has launched initiatives to support over 700 rural hospitals confronting rising cybersecurity threats and increasing digital demands. Through discounted access to security tools, free...
New Noninvasive DNA Methylation Test Detects Nasopharyngeal Cancer Early
Researchers have developed a novel diagnostic method using DNA methylation biomarkers from bilateral nasal swabs to detect nasopharyngeal carcinoma (NPC) noninvasively. Automated processing and...
Brain Resilience Markers Linked to Genetic Risk of Childhood Trauma Effects
A study published in Nature Communications reveals brain markers associated with resilience to childhood trauma that are modulated by genetic factors. The findings highlight how interplay between...